Securities Law Firm

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering

Press Release – New York, NY – July 11, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye (“EyeGate”).

Sichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering

Press Release – New York, NY – July 11, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented Vuzix Corporation in a firm commitment underwritten public offering of shares of common stock. The offering consisted of 1,150,000 shares of common stock, including continue reading >>

Sichenzia Ross Friedman Ference Congratulates DelMar Pharmaceuticals, Inc. on NASDAQ Uplisting

New York, NY – July 11, 2016 – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno.

Partner Harvey Kesner Represents Towerstream Corporation on $1.25 Private Placement

Press Release – New York, NY – July 11, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Towerstream Corporation (NASDAQ: TWER), a leading fixed-wireless fiber alternative company, on a private placement of 892,857 shares of Series B Preferred Stock and five year warrants to purchase 223,214 shares of common stock. Each preferred share is convertible into 0.5 shares of common stock and the warrants have an exercise price of $3.00.
continue reading >>

Partner Harvey Kesner Represents Towerstream Corporation on $2.28 Million Registered Direct Offering

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Towerstream Corporation (NASDAQ: TWER), a leading fixed-wireless fiber alternative company, on a registered direct offering of 15,000,000 shares of the Company’s common stock at a public offering price per share of $0.152 per share without an underwriter or placement agent. Each purchaser also received a five year warrant exercisable at $0.25 per share for each share of common stock purchased.

Partner Harvey Kesner Represents Chromadex Corporation on $5.25 Million Registered Direct Offering

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Chromadex Corporation (NASDAQ: CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, on a registered direct offering of 1,117,022 shares of the Company’s common stock at a public offering price per share of $4.70 without an underwriter or placement agent.

Sichenzia Ross Friedman Ference LLP Appoints Jeff Cahlon Counsel

New York, NY – (June 30, 2016) – Sichenzia Ross Friedman Ference LLP, the nationally ranked leading securities and corporate law firm, is pleased to announce today that it has promoted Jeffrey Cahlon to counsel from associate.

Mr. Cahlon joined the firm in 2007. His practice focuses on representing issuers, underwriters and investors in corporate financing transactions, including public and private equity and debt securities offerings, mergers and acquisitions, Exchange Act and Securities Act reporting and compliance, and general corporate and securities law.

“We are pleased to promote Jeff,” said founding partner Gregory Sichenzia. “Over the past nine years with us he has consistently demonstrated legal excellence and shown himself as an expert in a specialized and complex space.”

Mr. Cahlon’s full biography is available here: http://srfkllp.com/jeffrey-cahlon/

Partner Harvey Kesner Worked with Other Counsel to Successfully Petition for Removal of Defamatory Web Postings

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that partner Harvey Kesner and associate Cass Sanford, together with other counsel, successfully petitioned for removal of defamatory web postings from Google and Ripoff Report. continue reading >>

Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock

Press Release – New York, NY – June 23, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.

Press Release – New York, NY – June 21, 2016 – Nationally recognized securities and corporate law firm, Sichenzia Ross Friedman Ference LLP, announced today that it has represented Joseph Gunnar & Co. LLC as sole book-running manager in a firm commitment underwritten public offering of shares and warrants of Intellicheck Mobilisa, Inc.

Partner Gregory Sichenzia Quoted in Los Angeles Times article on Uber’s Entry into Leveraged Loan Market

New York, NY – June 16, 2016 – Partner Greg Sichenzia was quoted in a Los Angeles Times article titled “Uber reportedly seeks to raise up to $2 billion in the leveraged loan market”. The article discusses Uber’s engagement of Morgan Stanley and Barclays to sell a leveraged loan of $1 billion to $2 billion to institutional investors. Leveraged loans are similar to junk bonds in that they are deemed high risk, but return higher yields. Greg shared his views on the expected interest rates of the leveraged loans.

Read the full article here.

Partner Gregory Sichenzia Writes “3 Fundraising Options to Consider During a Tepid IPO Market” for Huffington Post

June 13, 2016 – Partner Greg Sichenzia wrote an article for Huffington Post Business titled “3 Fund Raising Options to Consider During a Tepid IPO Market.” The article describes three types of financing activities private companies that want to raise funds to list on a national exchange can consider as an alternative to the traditional underwritten IPO: private investments in public equity, or PIPEs, reverse mergers, and partnerships with existing corporations.

Read the full article here.

Partner Gregory Sichenzia Quoted in a Los Angeles Times article on Microsoft’s Purchase of LinkedIn

New York, NY – June 13, 2016 – Partner Greg Sichenzia was quoted in a Los Angeles Times article titled “Microsoft to buy networking site LinkedIn for $26.2 billion.” The article discussed Microsoft Corp.’s announcement today that it would acquire LinkedIn in a $26.2 billion all cash transaction that is expected to close this year. Greg said that the acquisition is a “big and bold step” for Microsoft and a “great deal for LinkedIn,” making Microsoft a more socially relevant company and providing LinkedIn with new capital to grow.

Read the full article here.

Partners Richard A. Friedman and Stephen A. Cohen Represent Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book Running Managers of PhaseRx, Inc.’s $18.5M IPO

Press Release – New York, NY – May 23, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book-Running Managers of the initial public offering of PhaseRx, Inc. (NASDAQ: PZRX).

Partners Marc Ross and James Turner Represent Taglich Brothers, Inc. in a $1.355 Million Private Placement

Press Release – New York, NY – May 19, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it represented Taglich Brothers, Inc. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Axiom Capital Management, Inc. In $1.2 Million Public Offering of iSign Solutions Inc.

Press Release – New York, NY – May 19, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Axiom Capital Management, Inc. as the underwriter in a firm commitment underwritten public offering of equity securities of iSign Solutions Inc. continue reading >>

Partner Greg Sichenzia to Participate in Panel on Uplisting to a National Exchange at the Marcum MicroCap Conference

Press Release – New York, NY – May 19, 2016 – Founding partner Greg Sichenzia will participate in a panel on uplisting to a national exchange at the 2016 Marcum MicroCap Conference in New York City on June 1, 2016 at 9AM. The panel will address what every company needs to know before, during and after an uplisting. The panel moderator will be Andrew Hall of Nasdaq and the other panelists will include Dave Donohoe of ROTH Capital Partners and Ramnarain Jaigobind of Joseph Gunnar & Co. LLC.
continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar and Fordham Financial Management in $7.5 Million Public Offering of Aytu Bioscience, Inc.

Press Release – New York, NY – May 9, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Joseph Gunnar & Co. LLC as sole book-running manager and Fordham Financial Management, Inc. as lead manager in a firm commitment underwritten public offering of equity securities of Aytu BioScience, Inc.

Partner Harvey Kesner Joins Client ChromaDex Corp. at NASDAQ Opening Bell Ceremony

Press Release – New York, NY – May 9, 2016 – Sichenzia Ross Friedman Ference LLP partner Harvey Kesner joined representatives of client ChromaDex Corp. including Frank L. Jaksch, Chief Executive Officer, Tom Varvaro, Chief Financial Officer, and Troy Rhonemus, Chief Operating Officer, at the NASDAQ MarketSite in Times Square to ring the May 6 opening bell. Also present at the opening ceremony was former Chromadex employee Jordan Kesner, Masters in Biotechnology and currently a Ph.D. candidate in Systems Biology at Columbia University.

Partner Jeffrey Fessler Represents Synergy Pharmaceuticals Inc. on $89.8 Million Registered Direct Offering of Common Stock

Press Release – New York, NY – May 6, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, on a registered direct offering of 29,948,334 shares of the Company’s common stock at a public offering price per share of $3.00 without an underwriter or placement agent.

Sichenzia Ross Friedman Ference LLP Represents DelMar Pharmaceuticals, Inc. in $7.5 Million Sale of Series B Preferred Shares

Press Release – New York, NY – May 5, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented DelMar Pharmaceuticals, Inc. in connection with the sale of $7,500,000 of its Series B Preferred Shares. DelMar Pharmaceuticals, Inc. was founded to develop and commercialize new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments.

Marc J. Ross, Esq. Speaks at Greenhouse Venture’s Cannabis Conference

Founding partner Marc Ross will be speaking at the Innovation in the Cannabis Industry: Technology, Medical & Investment conference on April 30th, where he will discuss Cannabis Investment Trends.

Please click here for more information on this event, and pass it along to anyone you think might be interested.

If you have any questions, please contact Marc at mross@srfkllp.com or (212) 398 – 5541.

Firm Participates in TechDay

April 20, 2016 – Tomorrow, Thursday April 21, 2016, Sichenzia Ross Friedman Ference LLP will be participating in TechDay, the largest startup event in the U.S. The firm will have a booth showcasing its Legal Services for Entrepreneurs practice group. The top venture capital firms, accelerators and over 550 tech companies are expected to participate. TechDay is open to the public and free to attend – come to learn about our services and to watch live demos or Shark Tank open casting calls.

Firm Ranked #4 and #5 in PrivateRaise’s Q1 PIPE League Tables

April 19, 2016 – Sichenzia Ross Friedman Ference LLP was ranked #4 placement agent counsel and #5 issuer counsel in PrivateRaise’s Q1 PIPE league tables. PrivateRaise, a service of The Deal, ranks the top investment managers, placement agents, placement agent legal counsel, issuer legal counsel, and investor legal counsel by the total number of placements advised each quarter.

Partner Gregory Sichenzia Quoted on IPO Activity

New York, NY – April 12, 2016 – Partner Greg Sichenzia was quoted in a Law360 article titled “Dormant IPO Market Could Pick Up Speed In 2nd Quarter”. The article discussed the recent uptick in IPO activity in the second quarter, but notes that concerns about valuations have postponed several IPOs this year. Greg noted that small to midsize biotech companies still face difficulties in obtaining IPO funding, forcing some to consider reverse mergers and other alternative routes to public markets.

Read the full article here.

Partner Harvey Kesner and SRFF Support South Florida After-School All-Stars

New York, NY – April 11, 2016 – Partner Harvey Kesner and Sichenzia Ross Friedman Ference LLP supported the All-In for All-Stars (“ASAS”) silent auction and poker tournament held on April 9, 2016 in Miami Beach, Florida. All proceeds benefited Arnold Schwarzenegger’s After-School All-Stars program that continue reading >>

Partner Gregory Sichenzia Appears on CNBC to Discuss Impact of New Fiduciary Rule on Broker-Dealers

Press Release – New York, NY– April 7, 2016 – Founding partner Gregory Sichenzia appeared on CNBC’s Closing Bell on April 6 where he debated the benefits and drawbacks of the new fiduciary rule announced that day by the Department of Labor. Greg noted that this new standard is likely to lead to substantial regulatory costs for small broker dealers and may not result in better products or targeted advice. A core part of the rule says that if advisers offering retirement advice want to continue receiving commissions and other types of compensation for selling specific products, they and their clients need to sign a “best interest contract” in which the adviser pledges to put the client’s interests first. That is stricter than the current standard, which only provides they need to offer “suitable” recommendations.

To view the video, click here.

Sichenzia Ross Friedman Ference LLP Represents Citius Pharmaceuticals Inc. in connection with its acquisition of LM Biosciences, Inc.

Press Release – New York, NY – March 8, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Citius in its acquisition of LM Biosciences, Inc. (“LMB”). LMB is a late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration of anti-infective drugs. continue reading >>

Partner Marc Ross to Discuss Investing in the Legal Marijuana Sector at the Growth Capital Expo

Press Release – New York, NY – April 6, 2016 – Founding partner Marc Ross will participate in a panel on the conflicting and ever-changing state of marijuana laws at the federal and state levels at the 2016 Growth Capital Expo on May 3-5 at Caesars Palace in Las Vegas. The panel will address the current state of affairs, the impact of the evolving state regulatory regimes governing medical and recreational use, and the future of the market’s federal status in the near and long term.

More than 15 hours of presentations and discussion panels are scheduled over the three days of the Expo, an event bringing together emerging growth company executives, investors and finance specialists. Other topics addressed will include the Reg A+ “mini-IPO” process, microcap shareholder activism and cybersecurity issues.

Visit here to learn more.

Partner Gregory Sichenzia Writes “Jumpstarting the IPO Market: Economic Factors to Watch in 2016” for Huffington Post

April 5, 2016 – Partner Greg Sichenzia wrote an article for Huffington Post Business titled “Jumpstarting the IPO Market: Economic Factors to Watch in 2016.” The article discusses recent macro and micro economic trends that may spark an uptick in IPO activity. These include an increase in public filings since January, greater stability in the global markets, cost cutting efforts by pre-IPO companies and opportunities for investors to enter the market near the bottom.

Read the full article here.

Partner Jeffrey Fessler Represents ContraVir Pharmaceuticals, Inc. on $7.0 Million Public Offering of Common Stock and Warrants

Press Release – New York, NY – April 5, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on continue reading >>

Partner Michael Ference Inducted Into the Bergen Catholic High School Hall of Fame

Press Release – New York, NY – March 30, 2016 – Sichenzia Ross Friedman Ference LLP is proud to announce that founding partner Michael Ference, Co-head of the firm’s litigation practice, was inducted into the hall of fame of his alma mater Bergen Catholic High School in Oradell, New Jersey during its annual hall of fame induction ceremony on March 20, 2016. Mr. Ference was honored for his achievements while a student at Bergen Catholic as well as for his personal and professional accomplishments thereafter.

Partners Richard Friedman and Harvey Kesner Sponsored Charity Tennis Tournament at Roth Conference

March 23, 2016 – Partners Richard Friedman and Harvey Kesner sponsored a tennis round robin tournament on March 13, 2016 at the ROTH Capital Partners 28th Annual Conference held in Orange County, California. continue reading >>

Partner Jeff Fessler Joins Client ContraVir Pharmaceuticals, Inc. at NASDAQ Opening Bell Ringing

Press Release – New York, NY – March 22, 2016 – Sichenzia Ross Friedman Ference LLP partner Jeff Fessler joined representatives of client ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, at the NASDAQ MarketSite in Times Square to ring the March 21 closing bell. continue reading >>

Sichenzia Ross Friedman Ference LLP Announces the Addition of Jeffrey R. Burke

Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that Jeffrey R. Burke, previously a partner in the securities litigation and regulatory enforcement practice of Winston & Strawn LLP has joined the securities litigation and regulatory practice of SRFF as a partner in its New York office. continue reading >>

Partner Gregory Sichenzia Quoted in U.S. News & World Report

March 14, 2016 – Partner Greg Sichenzia was interviewed for an article in U.S. News & World Report l titled “What to Expect for IPOs in 2016.” The article discusses the current status of the IPO market and predictions for future deal flow.

Read the full article here.

Sichenzia Ross Friedman Ference LLP Represents H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC as Joint Book Running Managers for $6.0 Public Offering and Uplisting to Nasdaq

Press Release – New York, NY – March 8, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented H.C. Wainwright & Co., LLC and Joseph Gunnar & Co. as joint book running managers in a firm commitment underwritten public offering of equity securities of LabStyle Innovations Corp.

Sichenzia Ross Friedman Ference LLP Represents Viatar CTC Solutions Inc. in a $4.2 Million Private Placement

Press Release – New York, NY – March 3, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Viatar CTC Solutions Inc., a medical technology company focused on the treatment of patients with metastatic cancer, in a private placement of $4.2 million of Series B Preferred Stock. continue reading >>

Partner Gregory Sichenzia Quoted in The Deal

March 2, 2016 – Partner Greg Sichenzia was interviewed for an article in The Deal titled “Credit Market Volatility Versus the Model.” The article discusses the effect of the market’s recent volatility on investment activity.

Read the full article here.

Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $6.9 Million Private Placement

Press Release – New York, NY – February 26, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Pershing Gold Corporation (NASDAQ: PGLC), a mining company (the “Company”). In connection with the offering, the Company accepted subscriptions for the sale of approximately $6.9 million in gross proceeds of 2,120,882 Units, with each Unit comprised of 1 share of Common Stock and a 30 month warrant to acquire 0.5 of a share of Common Stock at an exercise price of $5.06, at a price of $3.25 per Unit.

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in a $3 Million Registered Direct Offering

February 24, 2016 – New York, NY – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Amarantus BioScience Holdings, Inc. in a $3 million offering of the Company’s Series H Convertible Preferred Stock and Warrants to purchase common stock.

Partners Richard Friedman and Harvey Kesner Sponsor Tennis Round Robin at Roth Conference

February 24, 2016 – Partners Richard Friedman and Harvey Kesner will be sponsoring a tennis round robin tournament at the ROTH Capital Partners 28th Annual Conference held in Orange County, California. Join CAF athletes at the Monarch Beach Tennis Club on Sunday, March 13 from 1:00 to 3:00 pm for a round robin doubles tennis draw. Richard and Harvey will be playing and will match all donations of $100 or more. All proceeds will go to the Challenged Athletes Foundation.

Partner Gregory Sichenzia Discusses “Investing in a Down Market” for the Huffington Post

February 22, 2016 – Partner Greg Sichenzia wrote an article for Huffpost Business titled “Investing in a Down Market: Learnings From Warren Buffet and Other High Profile Investors.” The article provides an overview of current macroeconomic conditions and offers insights on investment opportunities and pitfalls in weak market conditions.

Read the full article here.

Partner Gregory Sichenzia Quoted on Biotech IPOs

February 22, 2016 – Partner Greg Sichenzia was quoted in a Law360 article titled “More Biotech IPOs Likely To Rely On Insiders Amid Slump.” The article discussed that more biotech companies are relying on support from inside investors to close deals due to weaker demand in the broader market. Greg noted that insider participation can be key to obtaining venture capital support.

Read the full article here.

Blog Post – Founding Partner Marc Ross Shares “Regulation A+: Funding The Start-up”

Overview

Start-ups looking to raise no more than $50 million now have the ability to do so by a Regulation A+ offering. The recent amendments to Regulation A, which is Regulation A+, under the Securities Act of 1933, as amended (the “Securities Act”), allow companies to increase the amount of capital that they can raise in a Regulation A offering from $5 million to $50 million over a 12-month period. continue reading >>

Firm Sponsors National Investment Banking Association (NIBA) Conference

NEW YORK, NY – February 9, 2016 – New York City based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it is proudly sponsoring the National Investment Banking Association (NIBA) Conference February 10th and 11th at the Margaritaville Hotel in Hollywood, Florida. Featured at the event will be two clients of the firm, EcoArk, Inc. and Green PolkaDot Box, Inc. (OTC:GPDB)

Bankruptcy Chair Ralph E. Preite Successively Guides Lundy’s Through Chapter 11 Bankruptcy Protecting All Assets

Partner Ralph E. Preite, Esq. successively guided Lundy’s Management Corp. through Chapter 11 bankruptcy reorganization to protect Lundy’s $20 million net lease for development of historic landmark waterfront real estate in Sheepshead Bay, Brooklyn, NY.

Partner Gregory Sichenzia Quoted on Alternatives to IPOs and Follow-On Deals

February 5, 2016 – Partner Greg Sichenzia was quoted in a Law360 article titled “Cold IPO Market Forces Companies To Get More Creative.” The article discussed that the weak market for initial public offerings and follow-on deals has companies scrambling for alternatives to meet their capital needs. Viable options for them to choose from exist, albeit none as ideal as a robust public market. Greg discussed the pros and cons of reverse mergers and Nasdaq’s and NYSE’s one-year “seasoning period” through which most companies must first trade over the counter while filing audited financial statements with the SEC.

Read the full article here.

Partner Arthur Marcus Judges at Startupalooza’s PITCH 2016 Competition

New York, NY – January 29, 2016 – Arthur Marcus, a partner in the firm’s corporate law group, acted as a judge in Startupalooza’s PITCH 2016 Competition on January 27, 2016. continue reading >>

Firm Again Ranked as #12 in Nation for Public Offerings

New York, NY – January 28, 2016 – For the second year in a row, Sichenzia Ross Friedman Ference LLP ranked as the #12 most active by the number of registration statements filed under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. continue reading >>

SRFF Litigation Attorney Ross Carmel Wins $1.5 Million in Damages

Press Release – New York, NY – January 27, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that litigation attorney Ross D. Carmel successfully represented a client in a business dispute. continue reading >>

Partner Marc Ross Shares “Cannabis Banking Problems Continue: U.S. District Court Shoots Down Cannabis Banking Rights”

It took “ten courageous citizens” recognizing the difficulty in obtaining banking services for marijuana-related businesses to form the Fourth Corner Credit Union in March 2014. continue reading >>

Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. in a Debt Facility for up to $10,000,000

Press Release – New York, NY – January 21, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented MabVax Therapeutics Holdings, Inc. continue reading >>

Partner Harvey Kesner Represents Investors in Restructuring of Beacher’s Madhouse and Terminating Lease With MGM Grand Las Vegas Hotel & Casino

Press Release – New York, NY – January 21, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented the investors in Beacher’s Madhouse, the world famous nightclub (the “Company”), in connection with a $2,500,000 restructuring of the Company’s capital structure and terminating the Company’s lease with the MGM Grand Las Vegas Hotel & Casino. continue reading >>

Partner Gregory Sichenzia Quoted on the Impact of Market Volatility on Biotech Issuers

January 19, 2016 – Partner Greg Sichenzia, whose clients include Swedish and Israeli biotech companies, was quoted in a Law360 article titled “Market Volatility Cools Attys’ Hopes For ‘JPMorgan Bounce’.” continue reading >>

The Deal Names Firm #1 Issuer Legal Counsel for Q4 and Quotes Partner Greg Sichenzia on Market Activity

January 18, 2016 – Sichenzia Ross Friedman Ference LLP was ranked #1 issuer counsel and #5 placement agent counsel in PrivateRaise’s Q4 PIPE league tables. continue reading >>

Founding Partner Marc J. Ross, Esq. Comments on the Launch of New York’s Medical Marijuana Program

Sichenzia Ross Friedman Ference founding partner Marc J. Ross, Esq. was recently asked to contribute insight for Marijuana Investor News’ article, “New York State Begins Medical Marijuana Sales.” This article discusses the limitations of our marijuana program as well as the expectations of the program in the future.

Please read the article here.

Partner Henry Nisser Featured by Swedish-American Chamber of Commerce after representing Oasmia Pharmaceutical AB

Press Release – New York, NY – January 14, 2016 – Sichenzia Ross Friedman Ference LLP is pleased to announce that Partner Henry Nisser was featured by the Swedish-American Chamber of Commerce, Inc. continue reading >>

Sichenzia Ross Friedman Ference LLP Again Ranks #1 as PIPE Issuer Law Firm for 2015

Sichenzia Ross Has Been the Nation’s Leader in PIPEs Transactions Since 2004

Also Ranked as Leading Investor and Placement Agent Counsel

Partner Harvey Kesner Represents Rant Inc. in Note and Warrant Financing

Press Release – New York, NY – January 14, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented Rant Inc. continue reading >>

Partner Gregory Sichenzia Interviewed on the Drop in Reverse Mergers For the PIPEs Report and TheStreet.com

January 12, 2016 – This week, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia was quoted in a PIPEs Report and TheStreet.com article titled “Reverse Mergers Dwindle in Favor of Other Offerings”. The article discussed the decline in reverse merger transactions in 2015 and the expected popularity of Regulation A+ offerings and self-underwritten offerings in 2016. Read the full article here.

Partner Marc Ross Announced as a Keynote Speaker at the Viridian Cannabis Investor Conference in NYC

New York, NY – January 12, 2016 – Sichenzia Ross Friedman Ference LLP partner Marc J. Ross will be a keynote speaker at the Viridian Cannabis Investor Conference on January 13, 2016 in New York City. continue reading >>

Sichenzia Ross Friedman Ference LLP Attorneys Join Client Oasmia Pharmaceutical AB at NASDAQ Opening Bell Ringing

Press Release – New York, NY – January 11, 2016 – Sichenzia Ross Friedman Ference LLP partners Gregory Sichenzia, Thomas Rose, Henry Nisser and Tara Guarneri-Ferrara and counsel Peter DiChiara joined representatives of client Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, at the NASDAQ MarketSite in Times Square to ring the January 11 opening bell. continue reading >>

Partner Harvey Kesner Represents Orbital Tracking Corp. in Preferred Stock and Note Financings

Press Release – New York, NY – January 7, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented Orbital Tracking Corp., a provider of satellite based tracking services and mobile voice and data communications, in two private placements for a total of $1,100,000. continue reading >>

Partner Marc Ross Represents Israeli Medical Marijuana Company OWC Pharmaceutical Research Corp. in Financing

Press Release – New York, NY – December 30, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented OWC Pharmaceutical Research Corp. continue reading >>

Partner Gregory Sichenzia Shares Why Higher Rates Drive Companies to Equity Markets, for Huffington Post

This week, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia discussed why higher rates drive companies to equity markets in his Huffington Post blog series. continue reading >>

Partner Marc Ross Provides Marijuana Investor Magazine With Legal Analysis on Marijuana at the Supreme Court

Sichenzia Ross Friedman Ference founding partner Marc Ross was recently featured in Marijuana Investor News’ article, providing legal analysis on marijuana at the Supreme Court. To read the entire article, please click here.

Partners Darrin Ocasio and Arthur Marcus Represent CBC Biotechnologies Inc. in Series A Preferred Stock Venture Financing

Press Release – New York, NY – December 24, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that the firm has represented CBC Biotechnologies Inc., a commercial solutions provider of cannabinoid based products with applications in the fields of pharmaceuticals, nutraceuticals and cosmetics/skin care, in connection with a $2,000,000 Series A venture financing with Tuatara Capital Fund I, L.P.
continue reading >>

Partner Richard Friedman Represents eMagin Corporation in $6M Registered Direct Offering

Press Release – New York, NY – December 23, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented eMagin Corporation (NYSE MKT: EMAN) (the “Company”), the leader in the development, design and manufacture of Active Matrix OLED microdisplays for high resolution imaging products, in connection with its $6,000,000 registered direct offering. continue reading >>

Partner Marc Ross Comments on What Marijuana Industry Leaders Really Want for Christmas

Sichenzia Ross Friedman Ference founding partner Marc Ross was recently featured in Marijuana Investor News’ article, “What Marijuana Industry Leaders Really Want For Christmas,” where he discussed the future of the marijuana industry and the changes that will likely ensue over time. Please read the article here.

Partner Harvey Kesner Represents MusclePharm Corporation in $6M Financing

Press Release – New York, NY – December 10, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented MusclePharm Corporation (OTCQX: MSLP) (the “Company”), a scientifically driven, performance-lifestyle sports nutrition company, in connection with its sale of a convertible secured promissory note in the principal amount of $6,000,000 to Ryan Drexler, the Executive Chairman of the Company. continue reading >>

San Francisco Business Times Interviews Gregory Sichenzia: “Square Prices IPO Well Under Target Range”

This week, San Francisco Business Times’ reporters Riley McDermid and Mark Calvey interview Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia on Square’s lower-than-expected IPO market cap. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Takung Art Co., LTD on $1.58M PIPE

Press Release – New York, NY – November 17, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that the Firm has represented Takung Art Co., a provider of an online platform for artists and creative professionals, in connection with a $1,580,000 private placement of the Company’s common stock priced at $1.58 per share.
continue reading >>

Partner Harvey Kesner Represents ChromaDex on $2M Registered Direct Offering of Common Stock and Warrants

Press Release – New York, NY – November 17, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented ChromaDex Corp. continue reading >>

Partner Gregory Sichenzia Interviewed by The Street: As Twitter and GoPro Plunge, What Does That Mean For Upcoming IPOs?

This week, The Street’s Rex Crum interviewed Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia on how major big brand tech stock prices having been dropping recently. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Genius Brands International on $4.3M PIPE

New York, NY – November 9, 2015 – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented global content and brand management company Genius Brands International, Inc. continue reading >>

Partner Gregory Sichenzia Interviewed by Law360: “10 Firms to Steer Nearly $1B in IPOs Following Long Lull”

Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia was interviewed last week by Law360’s Tom Zanki on the 10 firms that are currently counseling nearly a $1 billion worth of IPOs for the week of Nov 9, 2015. continue reading >>

Partner Gregory Sichenzia Reviews IPO Trends for Q4 2015 in Huffington Post

This week, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia discussed IPO trends for 2015 in his Huffington Post blog series. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Calpian, Inc. on $2.1M PIPE

New York, NY – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented global mobile payments technology and processing company, Calpian, Inc. (the “Company”), in connection with a private offering whereby the Company sold to accredited investors an aggregate of 3,558,335 shares of common stock and warrants to purchase up to 1,779,169 shares of common stock for a purchase price of $0.75 per share. The Company received $ 2,135,000 in gross proceeds from the sale of the securities. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Oppenheimer and Co. and H.C. Wainwright as Placement Agents on UQM Technologies’ $6.4 Million Registered Direct Offering

October 30, 2015 – New York, NY – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented investment bank Oppenheimer & Co. Inc. and Rodman and Renshaw, a division of H.C. Wainwright & Co. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Oasmia Pharmaceutical AB on $9.5M IPO and U.S NASDAQ listing

SRFF LLP Advises Fifth Swedish IPO on U.S. NASDAQ

October 28, 2015 – Press Release – New York, NY –Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today the Firm has represented Oasmia Pharmaceutical AB (NASDAQ: OASM) (NASDAQ Stockholm: OSAM.ST), a Swedish biopharmaceutical company focused on developing innovative treatments within human and animal oncology, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at an offering price of $4.06 per ADS. continue reading >>

Partner Gregory Sichenzia Speaks to Law360: “Seven Firms to Guide $1.5B in IPOs Led by Ferrari”

Last Friday, Law360’s Tom Zanki spoke to Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia about Ferrari’s upcoming IPO slated to be valued at $1.5B. continue reading >>

Partner Gregory Sichenzia Interviewed by Omaha World Herald: Biggest Winners in First Data’s IPO? The Workers

This week, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia was featured in Omaha World Herald’s article regarding global payment technology provider First Data’s initial public offering listed today. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli Biotech Company Can-Fite Biopharma on $4.8M Registered Direct Offering of ADSs

New York, NY – Press Release – October 15, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), an Israeli biotechnology company advancing a pipeline of proprietary small molecule drugs that addresses cancer and inflammatory diseases, on a registered direct offering with institutional investors where the Company issued 1,109,196 American Depository Shares (ADSs) at a purchase price of $4.35 per ADS. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents ContraVir Pharmaceuticals, Inc. on $15 Million Public Offering of Common Stock and Warrants

Press Release – New York, NY – October 14, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, on an underwritten public offering of 5,000,000 shares of the Company’s common stock and warrants to purchase up to 3,000,000 shares of common stock at a combined public offering price of $3.00. continue reading >>

Gregory Sichenzia Interviewed in the Financial Times: Discusses SEC’s Quiet Period Rules for Ferrari’s Upcoming IPO

Last week, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia spoke to James Fontanella-Khan and Nicole Bullock of the Financial Times on the latest controversy surrounding the major Italian sports car manufacturer Ferrari S.p.A’s upcoming IPO. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Rightscorp in $1.032M PIPE

October 9, 2015 – New York, NY – Press Release – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Rightscorp, Inc., a technology company that provides monetization services for holders of copyrighted intellectual property (OTCQB:RIHT) in a private placement offering where the Company sold to accredited investors 10,320,000 shares of common stock and warrants.
continue reading >>

Gregory Sichenzia Featured in Law360: Pure Storage’s Bumpy Debut Could Dampen Tech IPO Hopes

Yesterday, Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia was featured in Law360’s article to provide his thoughts on the launch of Pure Storage data flash storage supplier’s IPO this week. continue reading >>

Nine SRFF LLP Attorneys Named Super Lawyers & Rising Stars

New York, NY — October 2, 2015 — Press Release — Sichenzia Ross Friedman Ference LLP is pleased to announce that four Partners have once again been named 2015 New York Metro Super Lawyers. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents OriginClear, Inc. in $1.5M Acquisition of Progressive Water Treatment, Inc.

New York, NY – October 1, 2015 – Press Release—Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented OriginClear, Inc. (OTC:OOIL) continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in $5.5M Registered Direct Offering and Private Placement

October 1, 2015 — New York, NY – Press Release – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS), a biotechnology company developing therapeutic and diagnostic product candidates for orphan indications and neurology in a registered direct offering where Amarantus issued $2.75 million of newly designated Series H convertible preferred stock and warrants. continue reading >>

Partner Marc J. Ross Interviewed for Opportunist Magazine’s Cover Story

Oppportunist_Image_MJ Sichenzia Ross Friedman Ference LLP Partner Marc J. Ross was interviewed in the feature story last week by Opportunist Magazine. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs

New York, NY – Press Release – September 22, 2015 –Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Israeli biotechnology company, Can-Fite BioPharma (NYSE: CANF)(TASE: CFBI) on a public offering with institutional investors where Can-Fite received $9 million in gross proceeds. continue reading >>

Partner Gregory Sichenzia Interviewed by LA Times on Recent Stock Market Downturn

This week, LA Times reporters Chris Megerian and Phil Willon interviewed Sichenzia Ross Friedman Ference LLP Partner Gregory Sichenzia on the major stock market dip and current investor concerns. continue reading >>

Sichenzia Ross Friedman Ference LLP’s Israeli Affiliate DTKGC-SRFF Represents Spectronix in $100M Sale to Emerson Electric

Press Release – August 12, 2015 – Tel Aviv, Israel – DTKGC-SRFF, the Israeli affiliate law firm of Sichenzia Ross Friedman Ference LLP, announced today that the Firm has represented the Israeli fire detection sensor developer, Spectronix Ltd. continue reading >>

Archive

SRFF LLP Advises Fifth Swedish IPO on U.S. NASDAQ

Establishing and Navigating the Moving Parts of an IPO